Fresenius Medical Care AG & Co. KGaA

Report Publication Announcement • Apr 7, 2011

Fresenius Medical Care Profile 2010

Creating a future worth living

For people. Worldwide. Every day. More than three decades of experience in dialysis, innovative research, the global leader in dialysis services and products – that is Fresenius Medical Care.

Patients with kidney disease can now look ahead with much more confidence thanks to our innovative technologies and treatment concepts. We give them a future, one that offers them the best-possible quality of life.

As a vertically integrated company, we cover the entire dialysis value chain. We use the increasing demand for modern dialysis methods to our advantage and work consistently to enhance the Company's growth. Our focus is on consistently implementing strategies that enable us to uphold and expand our technological leadership.

We take the highest medical standards as our benchmark. This is our commitment to our patients, our partners in the healthcare system and our investors, who trust in the reliable performance and the future of Fresenius Medical Care.

O per at ing Data
Table 1 in \$ M
	2010	2009	Change
Selected key figures
Net revenue	12,053	11,247	7 %
Earnings before interest and taxes, depreciation and amortization (EBITDA)	2,427	2,213	10 %
Earnings before interest and taxes (EBIT )	1,924	1,756	10 %
Net income1	979	891	10 %
Net cash flow	1,368	1,339	2 %
Free cash flow2	861	777	11 %
Capital expenditure, net	507	562	–10 %
Acquisitions, net	618	136	354 %
Earnings per ordinary share in \$	3.25	2.99	9 %
Dividend per ordinary share3 in €	0.65	0.61	7 %
EBIT margin in %	16.0	15.6	–
Return on invested capital (ROIC) in %	8.8	8.5	–
Equity to assets in %	44.0	43.0	–

Net income attributable to Fresenius Medical Care AG & Co. KGaA.

Before acquisitions and dividends.

2010: Proposal to be approved by the Annual General Meeting on May 12, 2011.

Fr esen ius Medic a l Ca r e: Clin ics wor ldw ide Number Table 5
	2010	2009	Change
North America	1,823	1,784	2 %
Europe/Middle East/Africa	499	435	15 %
Latin America	193	191	1 %
Asia-Pacific	242	143	69 %
tota l	2,757	2,553	8%

wor ldw ide 2010 Patients Chart 6 Total: 2.029 M 137,689 North America Fresenius Medical Care 125,000 DaVita 13,500 Dialysis Clinics Inc. 38,061 Europe Fresenius Medical Care 18,500 Kuratorium für Heimdialyse 13,000 Diaverum 16,427 Asia-Pacific Fresenius Medical Care 7,200 Showai-Kai 4,200 Zenjin-Kai 22,471 Latin America Fresenius Medical Care 8,400 Baxter	Di a lysis services
Diaverum 3,500

Source: Based on company statements and estimates.

m a r k et posit ion in m a jor product groups 2010 Table 7
	Rank 1	Rank 2	Rank 3
Dialyzers	Fresenius Medical Care	Gambro	Nipro
Dialysis machines	Fresenius Medical Care	Gambro	Nikkiso
Hemodialysis concentrates	Fresenius Medical Care	Fuso	Gambro
Bloodlines	Fresenius Medical Care	Gambro	Kawasumi
Peritoneal dialysis products	Baxter	Fresenius Medical Care	Gambro

Source: Based on company statements and estimates.

214,648 patients worldwide

2,757 clinics worldwide

about 31.7 million dialysis treatments worldwide

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than two million individuals worldwide.

Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME,FME3) and the New York Stock Exchange (FMS, FMS/P).

May 4

Report on the first quarter 2011

May 12

Annual General Meeting Frankfurt am Main

May 13

Payment of dividend subject to the approval of the Annual General Meeting

August 2

Report on the second quarter 2011

November 2 Report on the third quarter 2011

Imprint Subject to change

Fresenius Medical Care AG & Co. KGaA Registered seat and commercial register: Hof an der Saale (Germany), HRB 4019 Chairman of the Supervisory Board: Dr. Gerd Krick General partner: Fresenius Medical Care Management AG Registered seat and commercial register: Hof an der Saale (Germany), HRB 3894 Management Board: Dr. Ben J. Lipps (Chairman), Roberto Fusté, Dr. Emanuele Gatti, Rice Powell, Michael Brosnan, Dr. Rainer Runte, Kent Wanzek Chairman of the Supervisory Board: Dr. Ulf M. Schneider